104
Participants
Start Date
November 1, 2024
Primary Completion Date
June 1, 2026
Study Completion Date
September 2, 2026
genotype-directed dosing with dosing software based on therapeutic drug monitoring
Genotype-directed dosing with dosing software based on therapeutic drug monitoring
Westmead Hospital, Sydney
Peter MacCallum Cancer Centre, Melbourne
Royal Brisbane & Women's Hospital, Brisbane
Children's Hospital Queensland, South Brisbane
Royal Adelaide Hospital, Adelaide
Sydney Children's Hospital Network, Sydney
Fred Hutchinson Cancer Centre, Seattle
Metro North Hospital and Health Service
UNKNOWN
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
OTHER
University of Sydney
OTHER
Western Sydney Local Health District
OTHER
Sydney Children's Hospitals Network
OTHER
Peter MacCallum Cancer Centre, Australia
OTHER
University of Melbourne
OTHER
Queensland Children's Hospital
OTHER_GOV
Royal Adelaide Hospital
OTHER
Pathology Queensland
UNKNOWN
Royal Brisbane and Women's Hospital
OTHER_GOV
The University of Queensland
OTHER